JAMP Pentoxifylline SR 400mg: Affected lot may contain Sitagliptin 100mg tablets.
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: JAMP Pentoxifylline SR
Issue: Health products - Product safety
What to do: Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type III
We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.
Get health product recall alertsCA$3.99/mo · cancel anytime
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|
| JAMP | JAMP Pentoxifylline SR | DIN 02543087 | Tablet (Extended-Release) | Pentoxifyllin 400mg | P3824001F |
Affected lot may contain Sitagliptin 100mg tablets